Skip to content

ROLE OF KUKKUTANDA TWAK BHASMA POWDER WITH SWAYAMBUVA GUGGULU tablet OVER SHUKTI BHASMA POWDER WITH LAKSHADI GUGGULU tablet IN THE MANAGEMENT OF BONE WEAKNESS (OSTEOPENIA/OSTEOPOR OSIS)

EFFECT OF KUKKUTANDA TWAK BHASMA WITH SWAYAMBUVA GUGGULU VATI OVER SHUKTI BHASMA WITH LAKSHADI GUGGULU IN THE MANAGEMENT OF ASTHIKSHAYA( OSTEOPENIA/OSTEOPOROSIS) - A RANDOMIZED COMPARATIVE CLINICAL STUDY. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083769
Enrollment
40
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. Subjects presenting with the classical signs and symptoms of Asthi kshaya. B. Subjects with BMD test value between -1 to -4 will be taken for the study. C. Subjects willing and able to participate in the study. D. Subjects of either gender aged between 40- 60 years.

Exclusion criteria

Exclusion criteria: A. Subjects already diagnosed with any serious systemic disorders which decline the general condition and interfere with the course of the disease and its management. Such as, Multiple myeloma, Osteomalacia, Rickets, Bone mineral disorders, Primary hyperparathyroidism, Metastatic bone malignancy. B. Subjects with Blood pressure of systolic pressure more than-150 & Diastolic pressure more than-100.

Design outcomes

Primary

MeasureTime frame
reduction in pain and may help in maintaining of overall health of boneTimepoint: 84 days

Secondary

MeasureTime frame
reduction in looseness of joints,may help in slowing down of bone resorption processTimepoint: 84 days

Countries

India

Contacts

Public ContactDr Sanjay M Kadlimatti

Bldeas avs amv hospital and research centre

ayursanjay@gmail.com8970744656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026